Press Release

CREMER OLEO has become the holder of the first CEP ever granted for a Medium-Chain Triglyceride (MIGLYOL® 812 N).

Published

Format: PDF file | Document type: Press Release

Cremer Oleo
Download PDF Now!

In order to provide you with this free service, William Reed Business Media Ltd will share your information with companies that have content on this site ("third parties"). By filling in this web form you signify your consent to this and to receiving communications from us, in accordance with our Privacy & Cookies Policy, and from the third parties by post, phone, email or SMS.

CREMER OLEO has gathered its activities for the pharmaceutical industry under the roof of CREMER Health, with a strong commitment to quality leadership in Oleoceuticals. 

Our pharmaceutical excipients for topical, oral and rectal applications as well as our oleo-chemical based active pharmaceutical ingredients for enteral and parenteral applications have been enjoying a good reputation for decades. 

Our strict adherence to quality is underpinned and rewarded with the repeated granting of an EU GMP-certificate as well as the availability of several regulatory documentations (US DMFs / CEP). 

Supplier info centre